Scholarly Index
Roman Hájek
University Hospital Ostrava; 36,482 total citations; 1,620 total publications; best world rank #49
University Hospital Ostrava
36,482Total citations
1,620Total publications
84H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 56 | CZ 1 | 99.55 |
| Peptidase Inhibition and Analysis | Lifetime | 179 | CZ 2 | 99.19 |
| Protein Degradation and Inhibitors | Lifetime | 73 | CZ 1 | 99.30 |
| Cancer Treatment and Pharmacology | Lifetime | 290 | CZ 1 | 99.12 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 135 | CZ 1 | 98.08 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 865 | CZ 3 | 97.94 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 471 | CZ 1 | 96.72 |
| Transportation Safety and Impact Analysis | Lifetime | 241 | CZ 1 | 94.71 |
| Structural Response to Dynamic Loads | Lifetime | 932 | CZ 2 | 93.87 |
| Education, Sociology, Communication Studies | Lifetime | 413 | CZ 3 | 76.40 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 49 | CZ 1 | 99.37 |
| Protein Degradation and Inhibitors | 2021-2025 | 52 | CZ 1 | 98.83 |
| Peptidase Inhibition and Analysis | 2021-2025 | 89 | CZ 1 | 97.72 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 532 | CZ 5 | 94.76 |
| Cancer Treatment and Pharmacology | 2021-2025 | 458 | CZ 1 | 91.23 |